Freerangers is temporarily offline. For supplement guidance, email Gary.
For longevity & proactive health

Annual mineral baseline. Multi-year trend data.

If you treat your health like a portfolio — measured, optimised, audited annually — HTMA is one of the cheapest and most informative annual data points you can add. Same lab, same methodology as our chronic-health work; the cadence is what changes.

"I treat it like a financial audit — once a year, eyes on the numbers, adjust if needed. The trend data is what makes it worth doing." — Longevity client, NZ
Why HTMA fits a longevity stack

Four reasons it earns its annual slot

Every annual longevity data point should justify itself on signal-to-cost. HTMA earns its place.

01

Tissue, not serum

Most longevity blood panels measure what's circulating. HTMA measures what's been deposited in tissue over 90+ days. You already have plenty of acute data — what you lack is tissue-level data.

02

Toxic metal trend tracking

Lead, mercury, cadmium, aluminium — the slow accumulators. Blood misses them; bone and tissue store them. HTMA is one of the few practical ways to track environmental burden across years without imaging.

03

Cost-effective at scale

$495/year for a Baseline Analysis is cheaper than most longevity blood panels and gives you data nothing else does. Annually, you build a multi-year picture for the cost of a couple of specialist visits.

04

Long-window resolution

Blood snapshots vary day-to-day; HTMA averages 90+ days. That long window makes year-over-year comparisons signal-rich, not noise-rich — which is what a longevity tracker should be.

The cadence

Annual baseline, once with a progress test in year one

For asymptomatic clients we typically recommend a Baseline + Progress Analysis bundle in year one, then annual Baseline Analyses. The pattern that emerges over four years is the actual product.

Year 1 · Q1
Initial baseline
First HTMA. Establishes your starting reference. May surface long-quiet patterns.
Year 1 · Q3
First Progress Analysis
Four to six months on. Confirms whether year-one protocol moved the needle. Sets the calibration.
Year 2 · Q1
Annual retest
Year-over-year comparison begins. Trend lines start to mean something.
Year 3+ · Q1
Standing routine
Slot it into your annual physical week. By year four, your trend data is the real asset.
What you actually track

The data points longevity-minded clients care about

For asymptomatic clients we focus interpretation on six specific things — the data lines that matter across years.

Toxic metal trend

Lead, mercury, cadmium, aluminium. Are accumulators going up, holding flat, or coming down? Year-over-year is where this becomes meaningful.

Stress signature stability

Ca:Mg and Na:K ratios as stress-overload markers. Stable across years = good. Drifting = something is changing in your stress economy.

Hormone balance markers

Zn:Cu over time. Particularly informative across hormonal life-stage changes (midlife, andropause, postnatal recovery).

Mineral floor maintenance

Are your magnesium, zinc, selenium, chromium holding mid-range or quietly draining over years? Tissue depletion accumulates slowly.

Metabolic rate signals

Ca:P as a thyroid-and-metabolism marker (how your body produces and uses energy). Useful across the slow midlife metabolic shift; surfaces issues before they're symptomatic.

Protocol response curves

If you've changed any nutrition or supplementation, your year-on-year HTMA tells you whether tissue actually responded — not just whether you felt different.

The cost math

What annual HTMA actually costs you

Five-year scenario

Year-1 Baseline + Progress + four annual Baseline Analyses

Year 1 spend
$895
HTMA Baseline + Progress Analysis bundle
Year 2–5 spend
$495 × 4 = $1,980
Annual Baseline Analysis retests
Five-year total
$2,875 NZD
All five years, full panel each time
Per-year average
~$575 / year
Less than most premium blood panels
What you get
Six full HTMA reports. A 5-year trend line on 35 minerals and metals. Year-over-year ratio movement. Toxic metal accumulation curve. Practitioner-curated protocol guidance throughout.
What it isn't
A substitute for your annual physical, blood work, or imaging. HTMA complements those — it doesn't replace them. Budget accordingly.
A composite case

Four annual tests, one slow win

Composite · Longevity client, four-year horizon

Male, 58, executive, asymptomatic. Wanted multi-year mineral baseline alongside annual blood work. Treated it as a longitudinal data exercise, not a symptom-driven test.

Year 1 surfaced moderately elevated lead — likely from his 1980s childhood home. Years 2–4 showed steady reduction with the supportive nutrition protocol. Zn:Cu also stabilised. By year 4 lead was within reference range. No clinical symptoms — the value here was risk reduction. He continues annually as part of his standing health routine.

— Composite case based on multi-year longevity clients Composite illustration. HTMA does not diagnose lead toxicity or any other condition. Outcomes vary; your situation is unique. See Client Results for more cases.
Which path

Year one: Baseline + Progress. Year two onward: annual Baseline Analysis.

For longevity clients: establish the trend-line in year one with the bundled Baseline + Progress Analysis, then use an annual Baseline Analysis as your standing check-in.

Year two onward

Annual Baseline Analysis

$495 / year
One test annually · NZD incl. GST

Slot it into your annual physical week. Most longevity clients run this for 5+ years — the multi-year picture is the real asset.

View Baseline Analysis

Add tissue data to your annual stack.

Most longevity routines are heavy on serum and light on tissue. HTMA fills that gap for less than the cost of a typical specialist visit per year. Start with the Baseline + Progress bundle this year; slot the annual Baseline Analysis in from year two.